Financial Times reporter Clive Cookson writes that MIT researchers have developed an ingestible pill that can deliver insulin directly to a patient’s stomach. “This discovery has the potential to transform not only drug delivery but drug discovery as well,” explains Prof. Robert Langer, “since most current drug discovery efforts are aimed at creating small molecule drugs that patients can take orally.”
MIT researchers have developed a new ingestible capsule that can release insulin directly into the stomach and could be used to treat type 2 diabetes, reports Joe Palca for NPR. "We chose the stomach as the site of delivery because we recognized that the stomach is a thick and robust part of the GI tract," explains visiting scientist Giovanni Traverso.
Wired reporter Megan Molteni writes that MIT researchers have developed an ingestible capsule that could be used to deliver insulin to diabetes patients. The researchers were inspired by the leopard tortoise to create a self-orienting device that can position itself to deliver medication directly into the stomach. “The result was a roly-poly-pill that autonomously rights itself to be needle-down,” Molteni explains.
Associated Press reporter Lauran Neergaard writes that MIT researchers have created a pea-sized pill that, once swallowed, can deliver medications such as insulin directly to the stomach. “The way this works is it travels down the esophagus in seconds, it’s in the stomach within a few minutes, and then you get the drug,” explains visiting scientist Giovanni Traverso.
Inspired by the shell of a leopard tortoise, MIT researchers have developed a self-orienting ingestible capsule that can deliver doses of medication to the stomach, writes Megan Thielking for STAT. “If we’re able to deliver large molecules orally, it would not only change drug delivery but also drug discovery,” says Prof. Robert Langer.
A team of MIT researchers has created a tiny ingestible device that deliver medications such as insulin directly to the stomach and could replace the daily injections used to treat diabetes patients, reports Alice Park for TIME. “We see no reason why someday this couldn’t be used to deliver any protein to the body,” says Prof. Robert Langer.
Boston Globe reporter Martin Finucane writes that MIT researchers have developed an ingestible capsule that contains a small needle that injects insulin directly into the stomach. Finucane writes that the researchers “designed the pill with a special shape to ensure that it will fall and then orient itself at the bottom of the stomach so that the needle is facing toward the stomach lining rather than the stomach’s inside.”
Researchers at MIT have developed an expandable pill that can stay in the stomach for a month and could potentially track issues like ulcers and cancers. “The pill is made from two types of hydrogels -- mixtures of polymers and water -- making it softer and longer-lasting than current ingestible sensors,” reports Robert Preidt for HealthDay.
Washington Post reporter Peter Holley writes that MIT researchers have developed a new ingestible, expanding pill that can remain in the stomach for up to a month and could be used to help with weight loss or to monitor conditions inside the human body. “The pills could also be used to place tiny cameras inside the body that could monitor tumors and ulcers over time,” Holley explains.
MIT researchers have developed a new ingestible pill that expands once it reaches the stomach and could be used to monitor a patient’s health, reports the BBC News. “The dream is to have a smart pill, that once swallowed stays in the stomach and monitors the patient's health for a long time, such as a month,” explains Prof. Xuanhe Zhao.
STAT reporter Casey Ross writes about how MIT researchers have developed a new ingestible Prof. Timothy Lu explains that he hopes that the sensor “opens up a really new window into how the gut and the rest of the body are connected, and hopefully provide new diagnostic strategies as well.”
MIT researchers have developed an inhalable form of messenger RNA that could be used to help treat patients with lung disease, reports Christopher Intagliata for Scientific American. Intagliata explains that researchers hope to one day “use this technique to help cystic fibrosis patients.”
MIT researchers have developed a remote-controlled ingestible capsule that can be operated by a user’s smartphone, reports the Xinhua news agency. “The researchers envisioned that this type of sensor could be used to diagnose early signs of disease and then respond with the appropriate medication,” Xinhua explains.
HealthDay News reporter E.J. Mundell writes that MIT researchers have developed an ingestible capsule that can be used to monitor health a patient’s health. “The capsule could deliver drugs as well as sense the condition of its surroundings in the gut, including infections or allergic reactions,” Mundell explains.
MIT researchers have developed a new injectable material that can deliver medication through cartilage and could one day be used to help reverse osteoarthritis, reports Katie Camero for The Boston Globe. Camero explains that the new material “can penetrate deep into the tissue, delivering drugs that can potentially help the chondrocytes heal cartilage.”